BOLD
Boundless Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.48
−0.80%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.56
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- -$1.06
- EPS estimate
- -$1.06
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -11.5%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | -$1.06 | -$1.06 | In line | — |
| May 8, 2026 | -$0.51 | -$0.60 | Miss -17.65% | — |
| Mar 9, 2026 | -$0.52 | -$0.58 | Miss -11.54% | — |
| Nov 5, 2025 | -$0.53 | -$0.62 | Miss -16.98% | — |
| May 9, 2025 | -$0.68 | -$0.71 | Miss -4.41% | — |
| Mar 27, 2025 | -$0.74 | -$0.74 | In line | — |
| Nov 7, 2024 | -$0.76 | -$0.74 | Beat 2.63% | — |
| Sep 29, 2023 | — | -$0.59 | — | — |
| Nov 7, 2019 | -$1.07 | -$1.00 | Beat 6.54% | — |
| Aug 6, 2019 | -$1.04 | -$1.01 | Beat 2.88% | — |
| Feb 27, 2019 | -$0.91 | -$0.84 | Beat 7.69% | — |
| Nov 6, 2018 | -$0.88 | -$0.97 | Miss -10.23% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026